Analyzing ReWalk Robotics (NASDAQ:LFWD) & Envoy Medical (NASDAQ:COCH)

ReWalk Robotics (NASDAQ:LFWD) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership and analyst recommendations.

Institutional & Insider Ownership

26.8% of ReWalk Robotics shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 2.1% of ReWalk Robotics shares are owned by insiders. Comparatively, 0.7% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares ReWalk Robotics and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ReWalk Robotics	-159.76%	-28.19%	-23.29%
Envoy Medical	N/A	N/A	-100.39%

Analyst Ratings

This is a summary of recent ratings and price targets for ReWalk Robotics and Envoy Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ReWalk Robotics	0	0	1	0	3.00
Envoy Medical	0	0	2	0	3.00

ReWalk Robotics currently has a consensus price target of $9.00, indicating a potential upside of 88.28%. Envoy Medical has a consensus price target of $6.00, indicating a potential upside of 18.58%. Given ReWalk Robotics’ higher possible upside, equities analysts plainly believe ReWalk Robotics is more favorable than Envoy Medical.

Risk and Volatility

ReWalk Robotics has a beta of 1.99, suggesting that its stock price is 99% more volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.68, suggesting that its stock price is 168% more volatile than the S&P 500.

Valuation and Earnings

This table compares ReWalk Robotics and Envoy Medical’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ReWalk Robotics	$13.85 million	2.93	-$22.13 million	($2.87)	-1.67
Envoy Medical	$320,000.00	309.93	-$29.91 million	N/A	N/A

ReWalk Robotics has higher revenue and earnings than Envoy Medical.

Summary

ReWalk Robotics beats Envoy Medical on 6 of the 11 factors compared between the two stocks.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.